Search

Author/Creator Rispens, Theo

61. Novel approach to monitor intravenous immunoglobulin pharmacokinetics in humans using polymorphic determinants in IgG1 constant domains. Issue 4 (24th December 2021)

Authors:
van Tilburg, Sander J.; Jacobs, Bart C.; Ooijevaar‐de Heer, Pleuni; Fokkink, Willem‐Jan R.; Huizinga, Ruth; Vidarsson, Gestur; Rispens, Theo
Journal:
European journal of immunology
Issue:
Volume 52:Issue 4(2022)
Page Start:
609
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

62. Ocrelizumab Concentration Is a Good Predictor of SARS‐CoV‐2 Vaccination Response in Patients with Multiple Sclerosis. Issue 1 (2nd November 2022)

Authors:
van Kempen, Zoé L. E.; Hogenboom, Laura; Toorop, Alyssa A.; Steenhuis, Maurice; Stalman, Eileen W.; Kummer, Laura Y. L.; van Dam, Koos P. J.; Bloem, Karien; ten Brinke, Anja; van Ham, S. Marieke; Kuijpers, Taco W.; Wolbink, Gerrit J.; Loeff, Floris C.; Wieske, Luuk; Eftimov, Filip; Rispens, Theo;...
Journal:
Annals of neurology
Issue:
Volume 93:Issue 1(2023)
Page Start:
103
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

63. OTU-020 Altered FC and FAB glycosylation status in patients with IGG4-related sclerosing cholangitis and autoimmune pancreatitis. (8th June 2018)

Authors:
Culver, Emma; Bovenkamp, Fleur Sanne van de; Derksen, Ninotska; Cargill, Tamsin; Koeleman, Carolien; Neef, Lisa; Barnes, Eleanor; Aalberse, Rob; Wuhrer, Manfred; Rispens, Theo
Journal:
Gut
Issue:
Volume 67(2018)Supplement 1
Page Start:
A155
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

64. Parallel detection of SARS‐CoV‐2 epitopes reveals dynamic immunodominance profiles of CD8+ T memory cells in convalescent COVID‐19 donors. Issue 10 (14th October 2022)

Authors:
van den Dijssel, Jet; Hagen, Ruth R; de Jongh, Rivka; Steenhuis, Maurice; Rispens, Theo; Geerdes, Dionne M; Mok, Juk Yee; Kragten, Angela HM; Duurland, Mariël C; Verstegen, Niels JM; van Ham, S Marieke; van Esch, Wim JE; van Gisbergen, Klaas PJM; Hombrink, Pleun; ten Brinke, Anja; van de Sandt, C...
Journal:
Clinical & translational immunology
Issue:
Volume 11:Issue 10(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

65. Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis. Issue 11 (29th July 2022)

Authors:
Spekhorst, Lotte S.; Bakker, Daphne; Drylewicz, Julia; Rispens, Theo; Loeff, Floris; Boesjes, Celeste M.; Thijs, Judith; Romeijn, Geertruida L. E.; Loman, Laura; Schuttelaar, Marie‐Louise; van Wijk, Femke; de Graaf, Marlies; de Bruin‐Weller, Marjolein S.
Journal:
Allergy
Issue:
Volume 77:Issue 11(2022)
Page Start:
3398
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

66. Personalized extended interval dosing of natalizumab in MS: A prospective multicenter trial. (11th August 2020)

Authors:
van Kempen, Zoé L.E.; Hoogervorst, Erwin L.J.; Wattjes, Mike P.; Kalkers, Nynke F.; Mostert, Jop P.; Lissenberg-Witte, Birgit I.; de Vries, Annick; ten Brinke, Anja; van Oosten, Bob W.; Barkhof, Frederik; Teunissen, Charlotte E.; Uitdehaag, Bernard M.J.; Rispens, Theo; Killestein, Joep
Journal:
Neurology
Issue:
Volume 95:Number 6(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

67. Perspective of patients with autoimmune diseases on COVID-19 vaccination. (April 2021)

Authors:
Boekel, Laura; Hooijberg, Femke; van Kempen, Zoé L E; Vogelzang, Erik H; Tas, Sander W; Killestein, Joep; Nurmohamed, Michael T; Boers, Maarten; Kuijpers, Taco W; van Ham, S Marieke; Eftimov, Filip; Wieske, Luuk; Rispens, Theo; Wolbink, Gertjan J
Journal:
Lancet
Issue:
Volume 3:Number 4(2021)
Page Start:
e241
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

69. Response to: 'Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from the STRASS study' by Marotte et al. Issue 7 (9th May 2019)

Authors:
l'Ami, Merel J; Krieckaert, Charlotte L; Nurmohamed, Michael T; van Vollenhoven, Ronald F; Rispens, Theo; Boers, Maarten; Wolbink, Gerrit Jan
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79:Issue 7(2020)
Page Start:
e82
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

70. Response to: Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial' by den Broeder et al. Issue 10 (13th November 2017)

Authors:
l'Ami, Merel J; Krieckaert, Charlotte L M; Nurmohamed, Michael T; van Vollenhoven, Ronald F; Rispens, Theo; Boers, Maarten; Wolbink, Gerrit Jan
Journal:
Annals of the rheumatic diseases
Issue:
Volume 77:Issue 10(2018)
Page Start:
e68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗